Description
Continuously achieved YTD of Above 110% in year 2020,2021 respectively also achieved the award of best selling new launched product unit wise in my territory, Joined Novo Nordisk and completed basecap training, also launched reasearch molecule (Semaglutide) by the name of Ozempic for the managemnt of Type 2 Diabetes, specially focused on Endocrinology Specialty.
Education
University Of Peshawar
- 2015-2020 Pharm-D
Experience
Sami pharmaceuticals
- Jan 2020- March 2022 Medical Sales Officer
Novo Nordisk
- March 2022/ Continue Product Specialist